Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("NOBLE, Paul")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 22 of 22

  • Page / 1
Export

Selection :

  • and

A Thermodynamic Approach to Evaluation of the Severity of Transformer FaultsJAKOB, Fredi; NOBLE, Paul; DUKARM, James J et al.IEEE transactions on power delivery. 2012, Vol 27, Num 2, pp 554-559, issn 0885-8977, 6 p.Article

Fabrication of novel colloidosome microcapsules with gelled aqueous coresCAYRE, Olivier J; NOBLE, Paul F; PAUNOV, Vesselin N et al.Journal of material chemistry. 2004, Vol 14, Num 22, pp 3351-3355, issn 0959-9428, 5 p.Article

Devonian radiolarian ribbon cherts from the Karakaya Complex, Northwest Turkey: Implications for the Paleo-Tethyan evolutionOKAY, Aral I; NOBLE, Paul J; TEKIN, Ugur Kagan et al.Comptes rendus. Palévol. 2011, Vol 10, Num 1, pp 1-10, issn 1631-0683, 10 p.Article

CD44 deficiency leads to enhanced neutrophil migration and lung injury in Escherichia coli pneumonia in miceQIN WANG; TEDER, Priit; JUDD, Nancy P et al.The American journal of pathology. 2002, Vol 161, Num 6, pp 2219-2228, issn 0002-9440, 10 p.Article

Idiopathic Pulmonary Fibrosis: Lung Function Is a Clinically Meaningful Endpoint for Phase III TrialsDU BOIS, Roland M; NATHAN, Steven D; RICHELDI, Luca et al.American journal of respiratory and critical care medicine. 2012, Vol 186, Num 8, pp 712-715, issn 1073-449X, 4 p.Article

Analyses of efficacy end points in a controlled trial of interferon-γ1b for idiopathic pulmonary fibrosisKING, Talmadge E; SAFRIN, Sharon; STARKO, Karen M et al.Chest. 2005, Vol 127, Num 1, pp 171-177, issn 0012-3692, 7 p.Article

Fabrication of hairy colloidosomes with shells of polymeric microrodsNOBLE, Paul F; CAYRE, Olivier J; ALARGOVA, Rossitza G et al.Journal of the American Chemical Society. 2004, Vol 126, Num 26, pp 8092-8093, issn 0002-7863, 2 p.Article

Resolution of lung inflammation by CD44TEDER, Priit; VANDIVIER, R. William; DIANHUA JIANG et al.Science (Washington, D.C.). 2002, Vol 296, Num 5565, pp 155-158, issn 0036-8075Article

Chronic treatment in vivo with β-adrenoceptor agonists induces dysfunction of airway β2-adrenoceptors and exacerbates lung inflammation in miceRUI LIN; DEGAN, Simone; BRODY, Arnold R et al.British journal of pharmacology. 2012, Vol 165, Num 7, pp 2365-2377, issn 0007-1188, 13 p.Article

Serum Inter-α-Trypsin Inhibitor and Matrix Hyaluronan Promote Angiogenesis in Fibrotic Lung InjuryGARANTZIOTIS, Stavros; ZUDAIRE, Enrique; NOBLE, Paul W et al.American journal of respiratory and critical care medicine. 2008, Vol 178, Num 9, pp 939-947, issn 1073-449X, 9 p.Article

All-Cause Mortality Rate in Patients with Idiopathic Pulmonary Fibrosis: Implications for the Design and Execution of Clinical TrialsKING, Talmadge E; ALBERA, Carlo; BRADFORD, Williamson Z et al.American journal of respiratory and critical care medicine. 2014, Vol 189, Num 7, pp 825-831, issn 1073-449X, 7 p.Article

Regulation of plasminogen activator inhibitor-1 and urokinase by hyaluronan fragments in mouse macrophagesHORTON, Maureen R; OLMAN, Mitchell A; BAO, Clare et al.American journal of physiology. Lung cellular and molecular physiology. 2000, Vol 23, Num 4, pp L707-L715, issn 1040-0605Article

Surfactant Protein-D Regulates Effector Cell Function and Fibrotic Lung Remodeling in Response to Bleomycin InjuryAONO, Yoshinori; LEDFORD, Julie G; MUKHERJEE, Sambuddho et al.American journal of respiratory and critical care medicine. 2012, Vol 185, Num 5, pp 525-536, issn 1073-449X, 12 p.Article

Role of hyaluronan and hyaluronan-binding proteins in human asthmaJIURONG LIANG; DIANHUA JIANG; JUNG, Yoosun et al.Journal of allergy and clinical immunology. 2011, Vol 128, Num 2, pp 403-411, issn 0091-6749, 9 p.Article

A macrophage subpopulation recruited by CC chemokine ligand-2 clears apoptotic cells in noninfectious lung injuryJIURONG LIANG; JUNG, Yoosun; TIGHE, Robert M et al.American journal of physiology. Lung cellular and molecular physiology. 2012, Vol 46, Num 5, issn 1040-0605, L933-L940Article

Extracorporeal Membrane Oxygenation for Severe Refractory Respiratory Failure Secondary to 2009 H1N1 Influenza ATURNER, David A; REHDER, Kyle J; PETERSON-CARMICHAEL, Stacey L et al.Respiratory care. 2011, Vol 56, Num 7, pp 941-946, issn 0020-1324, 6 p.Article

Innate immune activation potentiates alloimmune lung disease independent of chemokine (C-X-C motif) receptor 3MARTINU, Tereza; KINNIER, Christine V; PALMER, Scott M et al.The Journal of heart and lung transplantation. 2011, Vol 30, Num 6, pp 717-725, issn 1053-2498, 9 p.Article

Airway inflammation and remodeling in asthma: Lessons from interleukin 11 and interleukin 13 transgenic miceZHOU ZHU; CHUN GUEN LEE; TAO ZHENG et al.American journal of respiratory and critical care medicine. 2001, Vol 164, Num 10, pp S67-S70, issn 1073-449X, 2Conference Paper

Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trialsNOBLE, Paul W; ALBERA, Carlo; VALEYRE, Dominique et al.Lancet (British edition). 2011, Vol 377, Num 9779, pp 1760-1769, issn 0140-6736, 10 p.Article

Forced Vital Capacity in Patients with Idiopathic Pulmonary Fibrosis: Test Properties and Minimal Clinically Important DifferenceDU BOIS, Roland M; WEYCKER, Derek; THOMEER, Michiel et al.American journal of respiratory and critical care medicine. 2011, Vol 184, Num 12, pp 1382-1389, issn 1073-449X, 8 p.Article

A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary FibrosisKING, Talmadge E; BRADFORD, Williamson Z; LEDERER, David J et al.The New England journal of medicine. 2014, Vol 370, Num 22, pp 2083-2092, issn 0028-4793, 10 p.Article

Efficacy and Safety of Nintedanib in Idiopathic Pulmonary FibrosisRICHELDI, Luca; DU BOIS, Roland M; DONG SOON KIM et al.The New England journal of medicine. 2014, Vol 370, Num 22, pp 2071-2082, issn 0028-4793, 12 p.Article

  • Page / 1